Back to Search
Start Over
Aridis' treatment of lung infections in CF patients granted orphan designation
- Source :
- The Fly. June 24, 2019
- Publication Year :
- 2019
-
Abstract
- Aridis Pharmaceuticals' Panaecintm was granted FDA orphan designation as a treatment of lung infections in patients with cystic fibrosis, according to a post to the agency's website. [Reference [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.590504317